1-5 of 5
Behrang Amini, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Extensive Changes of the Immune Microenvironment Are Associated with Progression from Precursor Stages to Multiple Myeloma

Elisabet E. Manasanch, MD, Guangchun Han, Zheng Zhang, Minghao Dang, Manisha Singh, Maliha Khan, MD, Shubhra Singh, Hans C. Lee, MD, Krina K. Patel, MD, Gregory P. Kaufman, MD, Behrang Amini, MD PhD, Qaiser Bashir, MD, Samer A. Srour, MD MS, Yago Nieto, MD, Muzaffar H. Qazilbash, MD, Zuzana Berkova, PhD, Pei Lin, MDDM,MDC, Donald Berry, MD PhD, Sheeba K. Thomas, MD, Donna M. Weber, MD, P. Andrew Futreal, Linghua Wang, PhD, Robert Z. Orlowski, MDPhD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-137555
Published: 2020
Journal Articles

AML Cells Alter Bone Homeostasis By Promoting the Formation of Immature Bone and Resorption of Mature Bone That Supports Leukemia Progression

Anudishi Tyagi, PhD, Bin Yuan, Stanley Ly, Fouad El-Dana, MD, Vinitha Mary Kuruvilla, MSc, Qi Zhang, PhD, Christine B Peterson, Xin Zhou, PhD, Benoit deCrombrugghe, Michael Andreeff, MD PhD, Marina Konopleva, MD PhD, Behrang Amini, MD PhD, Venkata Lokesh Battula, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27.
https://doi.org/10.1182/blood-2020-142777
Published: 2020
Journal Articles

Update of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant (AuSCT) in Patients (Pts) with Multiple Myeloma (MM)

Sheeba K. Thomas, MD, Jatin J. Shah, MD, Armando Morin, M.A., Ashley N. Morphey, M.S.N., Hans C. Lee, MD, Elisabet E. Manasanch, MD, Krina K. Patel, MD, Gregory P. Kaufman, MD, Swami P. Iyer, MD, Lei Feng, MS, Behrang Amini, MD PhD, Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD, Neeraj Saini, MD, Samer A. Srour, MD MS, Ralph J. Johnson, PhD, Brandon N. Crumpton, Mildred D. Stafford, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-139934
Published: 2020
Journal Articles

A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM)

Elisabet E. Manasanch, MD, Sundar Jagannath, MD, Hans C. Lee, MD, Krina K. Patel, MDMSc, Connor Graham, BA, Gregory P. Kaufman, MD, Sheeba K. Thomas, MD, Swami Iyer, Sham Mailankody, MBBS, Neha Korde, MD, Behrang Amini, MD PhD, Pei Lin, MDDM,MDC, Zuzana Berkova, PhD, Donna M. Weber, MD, Feng Lei, MS, Nikoletta Lendvai, MD PhD, Michelle Hildebrandt, PhD, Sattva S Neelapu, MD, Robert Z. Orlowski, MD, PhD, Ola Landgren, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3116.
https://doi.org/10.1182/blood-2019-123205
Published: 2019
Journal Articles

Updated Results of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant (AuSCT) in Patients (Pts) with Multiple Myeloma (MM)

Sheeba K. Thomas, MD, Jatin J. Shah, MD, Ashley N. Morphey, RN, Hans C. Lee, MD, Elisabet E. Manasanch, MD, Krina K. Patel, MDMSc, Carla P Miller, RN, Suzanne Phillips, RN, Brandon N. Crumpton, Ralph J. Johnson, PhD, Lei Feng, MS, Swaminathan P Iyer, MD, Behrang Amini, MD PhD, Donna M. Weber, MD, Robert Z. Orlowski, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1982.
https://doi.org/10.1182/blood-2018-99-116464
Published: 2018